Plus Products Strengthens Team with Addition of Chief Scientific Officer
Tony Deyes
October 28th, 2019
App, Exclusive, News, Top Story
Few areas are more important to the emerging cannabis industry than science.
Science drives innovation, not only in product development, but also in the development of best practices and efficiencies in cultivation, extraction, as well as production, and is the key ingredient in the intellectual property which is expected to play an increasingly pivotal role.
The science behind cannabis has been hampered for decades by prohibition and the negative stigma accompanying it, but the trend toward legalization is enabling greater scientific study and a better understanding of this incredible, highly-diverse plant and its many beneficial and medicinal effects. Due to the sheer number of products available, consumer choices are largely driven by quality, and the modern cannabis consumer is increasingly attracted to companies which can back up claims with scientific data and have devoted the time, resources, and expertise to developing products which offer consistent results tailored to specific experiences.
Already a leader in California’s edibles space, Plus Products Inc. (CSE: PLUS, OTCQX: PLPRF) has just announced the addition of Dr. Ari Mackler to its impressive team of chefs and food manufacturing experts in the newly-created position of Chief Scientific Officer.
Click here to see the company investor presentation
Dr. Mackler will lead evidence-based edible cannabis research efforts across the company’s entire portfolio of products, and brings with him over 20 years of research experience in the pharmaceutical, healthcare, and consumer goods industries, as well as experience in medical affairs and communications. He earned his Bachelor of Science in Biology from Loyola University, a Ph.D. in Neuro-Endocrinology & Immunology from Loma Linda University, and was a Fellow of Developmental & Molecular Biology at Albert Einstein College of Medicine at Yeshiva University.
He held positions with pharmaceutical giant Merck & Co, the Almond Board of California, the International Tree Nut Council, the Nutritional Research & Education Foundation, and Stem Cell Resource. As the VP of Clinical Development for The Wonderful Company, Dr. Mackler led health & wellness initiatives to help establish the diverse company as a global branded products leader.
Commenting on the appointment, Jake Heimark, Plus co-founder and CEO said, “Dr. Mackler has a long history of helping consumer product companies share a clear and scientifically-backed narrative around product benefits. Cannabis is a performance category, and the most successful brands will be those that understand and are able to clearly communicate why their products work. There are few researchers of Dr. Mackler’s caliber in the cannabis industry today, and we believe he will play an invaluable role not only for PLUS, but as a thought leader within the industry.”
As Plus Products’ Chief Scientific Officer, Dr. Mackler will pursue research relationships and clinical trials with academic institutions and private partners to drive innovations as the company endeavors to expand consumer understanding of cannabis, its effects, and potential benefits.
Click here to see the company investor presentation
Timely Appointment
The appointment comes at a critical time for Plus as it embarks on an ambitious expansion of its product offering and a physical expansion into Nevada. The company also plans expansions into Arizona, Illinois, Massachusetts, Michigan, and New York in the near future, as well as the national roll-out of its CBD line in partnership with John Legend and Casper Sleep.
Dr. Mackler said, “I have been intrigued by cannabis for years and saw a huge opportunity to apply my scientific and consumer products background for PLUS to help validate and articulate how their products may help people live better lives. I also believe scientifically-based education is vital to the future of the industry, and PLUS has focused their business processes in a way that ensures science is at the center of their product development DNA.”
Plus is California’s top-ranked gummies brand, boasting the #1 and #2 best-selling products, and the top CBD-only product in the state and #5 top-seller overall, according to BDS Analytics. Its infused edibles are available in over 360 licensed retailers across the state of California, and in Nevada, its cannabis-infused gummies are currently available in several Las Vegas dispensaries, including 3 Medmen locations, and are expected to be rolled out across Nevada in the coming weeks. Its line of 100% hemp-derived CBD infused gummies is now available for purchase at plusproducts.com nationwide.
Plus is currently developing a line of infused chocolates, expected in the new year. The company is also looking at a possible expansion into Canada, which legalized the sale of derivative cannabis products on October 17th, to begin the process of taking its brand global.
Click here to see the company investor presentation
To keep up with developments at Plus Products, keep watching this page, and visit https://plusproducts.com/.
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Tony Deyes
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Innovium is a global beverage and foods brands platform that builds on consumer market trends and takes them to scale.
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
